UK DRI Researcher receives prestigious Future Leaders Fellowship from UKRI
UK DRI fellow at UCL, Dr Marc Aurel Busche, has been named as a recipients of a new fellowship scheme run by UK Research and Innovation (UKRI).
Read ArticleUK DRI fellow at UCL, Dr Marc Aurel Busche, has been named as a recipients of a new fellowship scheme run by UK Research and Innovation (UKRI).
Read ArticleThe full results from a ground-breaking trial showing successful lowering of a toxic protein in the neurodegenerative condition Huntington’s Disease, have been published.
Read ArticleA research team led by Prof. Bart De Strooper, UK DRI Director, studied how specialised brain cells called microglia respond to the accumulation of toxic proteins in the brain, a feature typical of Alzheimer’s disease.
Read ArticleScientists and clinicians have described a new form of dementia that exhibits symptoms similar to Alzheimer’s disease, and suggest 20% misdiagnosis in patients over 80 years old.
Read ArticleThis Sunday, thousands of marathon runners will be pounding the streets of London, raising vital money for charities across the UK. Many will be powering ground-breaking dementia research by fundraising for the UK Dementia Research Institute (UK DRI) through the Dementia Revolution campaign.
Read ArticleWe were delighted to welcome a group of MPs to the UK DRI labs at UCL today, to discuss the significant impact of dementia to our society and the ground-breaking research seeking to change that.
Read ArticleA team led by Professor David Rubinsztein, UK DRI at Cambridge, have shown that a prescribed drug to treat high blood pressure may be effective in treating conditions such as Parkinson’s disease, Huntington’s disease and forms of dementia.
Read ArticleWe’re thrilled to officially appoint our seventh centre of the UK DRI, after a competitive search for a robust programme that asks new and fundamental questions on how to better support people with dementia.
Read ArticleTo tackle the challenge of dementias we must capitalise on the breadth of available resources and expertise, and build an integrated ecosystem. In this spirit, on 2 April 2019 the UK DRI hosted the first meeting with Directors of the UK major programmes.
Read ArticleUK DRI researchers, together with leading colleagues in Alzheimer’s disease across UCL and beyond, have utilised patient-derived stem cells to uncover the effects of mutation on the processing of a key protein implicated in disease progression.
Read ArticleBetween 19-20th March, over 500 delegates came together in the small town of Harrogate in Yorkshire for the annual Alzheimer’s Research UK (ARUK) Conference – a particular highlight in the dementia meeting calendar.
Read ArticleIt was announced yesterday (Thursday 21st March) that pharmaceutical companies Biogen and Eisai are to discontinue two phase III trials of the Alzheimer’s disease drug aducanumab.
Read ArticleDuring the visit, The Princess met with our directors to hear about their vision for the institute, toured one of our new laboratories and learned about some of the cutting-edge research underway.
Read ArticleJulie Williams, Associate Director, UK DRI at Cardiff heads the GERAD consortium who collaborated on a major new genetics study.
Read ArticleA lively symposium has marked the official opening of our King’s College London centre.
Read ArticleOn Monday 14th January UK DRI held its first live streamed event hosted at the UK DRI Hub at UCL.
Read ArticleHot off the press we are delighted to announce that a major new ‘Care Research & Technology’ programme has been selected to soon join the UK DRI.
Read ArticleA message from our UK DRI Directors
Read ArticleOur Directors comment on new findings from the UCL MRC Prion Unit.
Read Article5 December 2018: Summit meeting to drive global action to deliver the dementia solutions
Read Article